Transaction Details

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | This is the weighted average sales price representing 35,072 shares sold at prices ranging from $91.18 to $92.17 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | This is the weighted average sales price representing 18,319 shares sold at prices ranging from $92.20 to $93.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | This is the weighted average sales price representing 10,781 shares sold at prices ranging from $93.20 to $93.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | This is the weighted average sales price representing 34,500 shares sold at prices ranging from $95.00 to $95.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | This is the weighted average sales price representing 500 shares sold at prices ranging from $96.00 to $96.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.